Sign In for increased benefits

Turn your one-off questions into a powerhouse research hub.

  • 🚨Real-time alerts on your custom watchlists
  • 🔍Unlock Deep Research Mode
  • 📊Exportable PDF/Word reports
  • 📚Revisit every question in your account history
  • ⭐Get personalised research and news based on your past questions
  • 🤝Team collaborate & annotate insights
  • 🌐Sync across devices—never lose your place
  • 👑Early-access to the next big AI features
  • 📚Continue enjoying 40 questions daily on your free account
About UsFAQsContact UsPrivacy PolicyCookies PolicyTerms and ConditionAcceptable Use PolicyData Processing Addendum
📢 New Earnings In! 🔍
Latest EarningsEarnings ChatEarnings FeedCompanies

SIGA Technologies, Inc.

SIGA

Healthcare
Drug Manufacturers - Specialty & Generic
US

Company Overview

Detailed information about SIGA Technologies, Inc.

Basic Information
Ticker: SIGA
Country: US
Headquarter: New York City, NY
Employees: 46
Financial Information
Market Cap: $492.9 Million
Currency: USD
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Stock Data provided by Financial Modeling Prep

Company Description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

Last Updated: Jul 2025

Here's what you can ask